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ORIGINAL ARTICLE
Bronchogenic cyst (BC) is a congenital lesion and
represents one of many bronchopulmonary mal-
formations. BC presumably represents supernu-
merary lung buds from the primitive foregut. BCs
occur more frequently in the mediastinum around
the tracheobronchial tree when they form early or
within the pulmonary parenchyma if they develop
later.1–4 Intrapulmonary BCs typically present as
thin-walled cystic lung parenchymal lesions with
water content and are reported in about 15–23%
of all BCs.3,4 Intrapulmonary BCs are not infre-
quently detected by ultrasound at the prenatal 
or neonatal stage.3–5 The clinical presentations of
intrapulmonary BCs are variable from those of
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Background/Purpose: Bronchogenic cysts (BCs) are usually located in the mediastinum and they occur
less commonly in the lung parenchyma. This study investigated the findings from computed tomography
(CT) images, clinical presentation and histopathologic findings of intrapulmonary BCs.
Methods: From the last 7 years, the CT images of 20 patients (12 females, 8 males; mean age, 38.8 ± 21.7
year; median age, 34 years) with intrapulmonary BC were available. Contrast-enhanced CT findings 
were characterized and correlated with clinical presentation and histopathologic findings (using Fisher’s
exact tests).
Results: The majority of intrapulmonary BCs were subpleural in location (55%), in the lower lobes
(60%), symptomatic (80%), and in adults (90%). Three CT patterns were identified: cyst with content of
fluid attenuation (9 patients), cyst with air and fluid content (9 patients), cyst with content of soft tissue
attenuation (2 patients). Preoperative diagnosis of intrapulmonary BC was correct in only 20% using the
CT criteria of cysts with fluid attenuation and without anomalous blood supply. Cysts with air component
were significantly larger than those without air component (p = 0.0452), but cyst size and air component
were not correlated with clinical presentation. Surrounding infiltration or thick wall on CT were signifi-
cantly correlated with the presence of any clinical symptom (p = 0.014) or fever (p = 0.042). CT findings of
surrounding consolidation, ground glass opacity or thick wall were significantly correlated with chronic
inflammation or pneumonic change on histopathology (p = 0.0008).
Conclusion: There is a wide spectrum of intrapulmonary BCs that have CT findings that are correlated
with clinical presentations and histopathologic findings. [J Formos Med Assoc 2007;106(1):8–15]
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incidental radiologic findings without symptoms
to abnormal radiographic findings associated with
clinical symptoms.3,4 Variable radiologic presen-
tations of intrapulmonary BCs were also reported
from well-defined cysts with water attenuation to
complete air-filled cysts or cysts with air–fluid
levels.3–7 Although radiographic, computed tomo-
graphy (CT), magnetic resonance imaging (MRI)
findings of intrapulmonary BCs have been de-
scribed,3,6,7 the number of CT studies are few. In
this study, we conducted a retrospective review 
of the CT images of a case series of 20 intra-
pulmonary BCs and correlated their CT patterns
with the clinical presentations and histopathologic
findings.
Patients and Methods
Intrapulmonary BC was defined as a BC that was
located within the lung parenchyma and con-
firmed intraoperatively and by histopathology.
Between January 1995 and December 2002, 27
patients had pathologically diagnosed intrapul-
monary BC in our hospital. Twenty (12 females,
8 males; mean age, 38.8 ± 21.7 year; median age,
34 years; age range, 4 months to 76 years) of the
27 patients had chest CT available. Among the
20 patients, there were 18 adults, one 15-year-old
boy and one 4-month-old male infant. Seven of
the 20 patients were older than 50 years of age.
All patients underwent surgical resection, includ-
ing lobectomy (15 patients) and partial wedge
resection (5 patients). All fulfilled the diagnostic
criteria of intrapulmonary BC. The intrapulmo-
nary location of the cysts was confirmed during
surgery and by histopathologic evidence of bron-
chial glands, cartilage, smooth muscle and, occa-
sionally, calcifications and/or ossification foci.1
The CT studies were performed without and with
intravenous contrast enhancement in three patients
and only with intravenous contrast enhancement
in the remaining 17. CT studies were performed
in the following ways: using contiguous 6 mm
sections at 6 mm intervals (13 patients) (C150,
Imatron; GE Healthcare, Milwaukee, WI, USA);
10 mm sections at 10 mm intervals (4 patients);
and 5 mm sections at 5 mm intervals (3 patients)
(HiSpeed; GE Healthcare). All CT images with
contrast enhancement were reviewed.
The location, size and morphology (includ-
ing the components of the cysts or adjacent lung
parenchyma) of all intrapulmonary BCs on the
hard copies of contrast-enhanced CTs were re-
viewed and recorded by the consensus reached
by two radiologists who had 12 and 5 years of
experience of thoracic imaging (YCC and TCW),
respectively. The locations of intrapulmonary BCs
were classified as subpleural, mid-lung and peri-
hilar, depending on where the major part was. The
distribution of the intrapulmonary BC was also
recorded depending on which lung lobe was 
located. CT images with contrast enhancement
were categorized according to the cystic content:
type 1 cysts had fluid attenuation content only;
type 2 cysts had both air and fluid attenuation
content; type 3 cysts had soft tissue attenuation
content isodense to chest wall muscle and cystic
wall. Fluid attenuation content was defined as 
the cyst having lower attenuation than that of 
enhancing chest wall muscle based on visual per-
ception on hard copies in window setting level −
500 HU to −750 HU and width 1000 HU to
1500 HU for lung parenchyma, and level 20 HU
to 35 HU and width 300 HU to 500 HU for me-
diastinum. Wall thickness was defined as “thin” if
the thickest part of the cystic wall was ≤ 3 mm on
enhanced CT, while a “thick” wall was considered
if the thickest part was > 3 mm. It was subcate-
gorized into “a” and “b” for each individual type,
where “a” indicated a thin-walled cyst with clear
interface and no infiltration of the surrounding
lung parenchyma and “b” indicated a thick cystic
wall or with infiltration of the surrounding paren-
chyma. Surrounding lung parenchymal change
of intrapulmonary BC was defined in terms of
consolidation and/or ground glass opacity. Em-
physema was recorded based on available CT 
images because it was reported to be an associ-
ated finding of intrapulmonary BC in a previous
study.6 The clinical history, preoperative diagno-
sis and all major clinical symptoms including
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productive cough, dry cough, blood-tinged spu-
tum, hemoptysis, chest pain, dyspnea, fever, chills,
were reviewed based on the medical records. Patho-
logic specimens of the cysts were reviewed by an
experienced pulmonary pathologist. The patho-
logic findings of surrounding lung parenchyma
were also recorded.
All analyses were performed using SAS ver-
sion 8.2 (SAS Institute Inc., Cary, NC, USA) for
Microsoft Windows. A p value < 0.05 was consid-
ered statistically significant. Group comparisons
were conducted using Fisher’s exact tests for pro-
portions and general linear models for contin-
uous variables. Correlations between types and
sizes of intrapulmonary BCs and clinical symp-
toms were performed with Fisher’s exact test. Cor-
relations of CT patterns, including the presence
of air or surrounding parenchymal change, with
each symptom and the presence of any symptom
were performed. Histopathologic findings of sur-
rounding lung parenchymal change (pneumonia
or inflammation) were correlated with CT evi-
dence of surrounding consolidation, ground glass
opacity or thick wall (category b).
Results
CT findings and patterns of 
intrapulmonary BCs
The Table shows the distribution of CT patterns.
Nine patients (45%) had type 1 cyst, nine (45%)
had type 2 cyst, and two (10%) had type 3 cyst.
Among the type 2 cysts, the percentage of air com-
ponent ranged from little (5%) to predominantly
air-filled cysts (15%), but the majority (25%) had
an approximately equal amount of air and fluid
component. The mean size of intrapulmonary BC
was 6.9 ± 4.6 cm (range, 1.2–20 cm). Type 2 cysts
with air component (9.6 ± 4.9 cm) were signifi-
cantly larger in size (p = 0.0452). Calcified spots of
the cystic wall were found in two patients (10%),
including one type 1 (Figure 1) and one type 2 in-
trapulmonary BC. In type 3 cysts, wall thickness
could not be evaluated. There were multiple
locules of intrapulmonary BC in nine patients and
a single locule of intrapulmonary BC in 11 pa-
tients. Consolidation and ground glass opacity
were found adjacent to or surrounding the cysts in
11 patients (55%). There were eight cysts (40%)
Table. Clinical features and computed tomography patterns of 20 patients with intrapulmonary bronchogenic cysts*
Type I, simple cyst Type II, cyst with air Type III, soft tissue mass Total
p†
(n = 9) (n = 9) (n = 2) (n = 20)
Sex, male/female 3M/6F 5M/4F 0M/2F 8M/12F 0.538
Age, yr 37.9 ± 17.6 36.9 ± 25.9 51.5 ± 27.6 38.8 ± 21.7 0.705
Symptoms
Chest pain 3 (33) 2 (22) 0 (0) 5 (25) 1.000
Dry cough 1 (11) 1 (11) 0 (0) 2 (10) 1.000
Productive cough 3 (33) 4 (44) 0 (0) 7 (35) 0.818
Blood-tinged sputum 1 (11) 2 (22) 1 (50) 4 (20) 0.420
Hemoptysis 1 (11) 3 (33) 0 (0) 4 (20) 0.733
Dyspnea 1 (11) 2 (22) 0 (0) 3 (15) 1.000
Fever 3 (33) 3 (33) 0 (0) 6 (30) 1.000
Chills 2 (22) 0 (0) 0 (0) 2 (10) 0.574
No symptoms 3 (33) 0 (0) 1 (50) 4 (20) 0.153
Leukocytosis 0 (0) 2 (22) 1 (50) 3 (15) 0.142
Size, cm 4.5 ± 3.1 9.6 ± 4.9 5.2 ± 0.2 6.9 ± 4.6 0.045‡
*Data are presented as mean ± standard deviation or n (%); †p values are from statistical comparison among the groups of patients with different CT 
patterns; ‡p < 0.05.
with wall thickness > 3 mm and 10 cysts (50%)
with wall thickness ≤ 3 mm. Fistula was found be-
tween cyst and bronchus in only two patients dur-
ing surgery: one was visible on CT while the other
was not visible on CT but found during operation.
The majority of the intrapulmonary BCs were
of subpleural location (55%), followed by mid-
lung (30%) and perihilar (15%). The distributions
of intrapulmonary BCs were in the right upper
lobe (2 patients), right middle lobe (1 patient),
right lower lobe (8 patients), left upper lobe 
(4 patients), left lower lobe (4 patients), and right
middle and upper lobe (1 patient). Lower lobes
(60%) were the most common location. Nine
patients had type 1 intrapulmonary BC (4 type 1a,
5 type 1b) (Figure 1), nine patients had type 2 in-
trapulmonary BC (3 type 2a, 6 type 2b) (Figure 2),
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Figure 1. A 22-year-old woman with a perihilar type 1a in-
trapulmonary bronchogenic cyst associated with a dense
calcified nodule in the right middle lung lobe.
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Figure 2. (A, B) A 48-year-old woman with a type 2 intrapulmonary
bronchogenic cyst (BC): (A) axial-enhanced computed tomography 
scan shows a cyst with surrounding mild consolidation and 
heterogeneous water attenuation content with entrapped air pockets;
(B) microscopically, one can see that the BC is lined by ciliated 
columnar epithelium with chronic inflammation and fibrous cystic wall
(hematoxylin & eosin; original magnification, 33×). (C) A 19-year-old
man with type 2 intrapulmonary BC with dominant air component 
that was diagnosed as an infected bulla before operation.
and two patients had type 3 intrapulmonary BC
(1 type 3a, 1 type 3b) (Figure 3). Two type 1a,
one type 1b and one type 2b intrapulmonary 
BC were correctly diagnosed before surgery. The
remaining two type 1a intrapulmonary BCs were
diagnosed incorrectly as metastatic tumors
(Figure 4) due to round shape and history of
colon cancer, and pulmonary sequestration due
to coexistence of a large pulmonary sequestra-
tion in the left lower lobe and a small BC near
the left hilum. All three type 2a intrapulmonary
BCs were diagnosed as bulla or bullae due to a
large amount of air component (Figure 2C). The
other five type 2b intrapulmonary BCs were con-
sidered lung abscesses due to air in the thick-
walled cyst and surrounding lung parenchymal
consolidation. Both two type 3 intrapulmonary
BCs were considered to be lung tumors before
operation due to soft tissue attenuation of cystic
content (Figure 3). The overall percentage of
preoperative correct diagnosis of intrapulmonary
BC was 20% (4/20). Surrounding regional hy-
poattenuation and vascular attenuation that
were compatible with CT findings of pulmonary
emphysema were found in two patients (1 type 2
cyst, 1 type 3 cyst).
CT patterns and clinical presentations of
intrapulmonary BCs
The majority of patients with intrapulmonary
BCs (80%) were symptomatic at initial presenta-
tion, including productive cough (7 patients), fever
(6 patients), chest pain (5 patients), hemoptysis
(4 patients), blood-tinged sputum (4 patients),
dyspnea (3 patients), dry cough (2 patients), and
chills (2 patients) (Table). Three patients with
type 1 and one type 3 intrapulmonary BC were free
of symptoms with incidentally found lung lesions
on chest radiographs. Two of the six patients with
fever were associated with leukocytosis and the
other two with chills (Table). No significant cor-
relation of different types of intrapulmonary BCs
was found with sex, age, clinical symptoms, or the
presence of leukocytosis (Table).
Six patients with intrapulmonary BC were
found to have infection due to single or multiple
pathogens, including Pseudomonas aeruginosa
(2 patients), Klebsiella pneumoniae (2 patients),
Aspergillosus fumigatus (2 patients), and Strepto-
coccus viridans (1 patient). One patient with type
1 intrapulmonary BC was diagnosed with acute
myeloid leukemia and superimposed infection
of the intrapulmonary BC with A. fumigatus. 
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Figure 4. A 58-year-old woman with a history of colon cancer
had a 12 mm round type 1a intrapulmonary bronchogenic
cyst in the mid-portion of the right lower lung lobe, mimick-
ing lung metastasis.
R
Figure 3. A 72-year-old woman with a type 3 intrapul-
monary bronchogenic cyst mimicking a solid lung mass in the
right lower lung lobe.
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One patient with a small type 1 intrapulmonary
BC had coexistent large intralobar bronchopul-
monary sequestration in the left lower lobe. Mild
hemoptysis occurred in four patients (20%), 
including one patient with type 1b intrapul-
monary BC and three with type 2b intrapulmonary
BC. Two patients had documented fistulae between
intrapulmonary BC and bronchial tree in surgery
but only one had hemoptysis. Our analysis
showed the significant correlation between the
presence of any clinical symptom and the pres-
ence of surrounding infiltration (i.e. consolida-
tion and/or ground glass opacity) or thick wall
(category b) on CT images (p = 0.014). Among
these clinical symptoms, significant correlation
between fever and category b was also noted (p =
0.042). Patients with any clinical symptoms or
fever had higher likelihood of lung parenchymal
change surrounding intrapulmonary BC on CT.
All patients with type 2 intrapulmonary BC
with the presence of air component (9/9, 100%)
had at least one clinical symptom. In contrast, only
seven of 11 intrapulmonary BCs without air com-
ponent (63.6%) were symptomatic. However, the
correlations of the presence of air component and
the presence of any clinical symptom were not
significant (p = 0.094). Besides, the size of intra-
pulmonary BC was not correlated with clinical
symptoms.
CT patterns and histopathologic findings 
of lung parenchyma surrounding
intrapulmonary BC
The cysts were usually lined by ciliated columnar
epithelium with variable acute and chronic in-
flammation. However, some of the components
might be destroyed when infection is present for
a long time. On histopathology, 12 of the 20 in-
trapulmonary BCs revealed chronic inflammation
(n = 7) (Figure 2) or pneumonic change (n = 5)
on adjacent lung parenchyma under microscopic
evaluation. Among the 12 patients with histo-
pathologic change in adjacent lung parenchyma,
eight had thick wall, and 11 had surrounding
consolidation or ground glass opacity on CT. In
the eight patients without histopathologic change
of surrounding lung parenchyma, only one had
thick wall and none had surrounding consolida-
tion or ground glass opacity on CT. The correlation
of histopathologic findings (chronic inflamma-
tion or pneumonic change) of intrapulmonary
BC with CT category b pattern was significant
(p = 0.0008).
Discussion
Intrapulmonary BC has a wide spectrum of im-
aging and clinical presentations. They are more
common in the lower lung lobes,6,8 as shown also
in our study. In this study, the subpleural region
of the lower lobe (55%) was the most common
location, followed by the mid-lung (30%) and
perihilar (15%).
In this study, we proposed a new CT classifi-
cation of intrapulmonary BC based on the attenu-
ation of the cyst, the presence of air, the thickness
of the cystic wall and surrounding lung parenchy-
mal change. Type 1a cysts with a sharply defined
thin-walled cyst and fluid attenuation content can
be more easily diagnosed on enhanced CT when
no systemic supplying vessel is found. Unfortu-
nately, type 1a intrapulmonary BC (20%) was
the minority type in our study. Type 2 intrapul-
monary BC may be completely air-filled or with
variable degrees of air–fluid level. Correct preop-
erative diagnosis of type 2 cysts may be difficult.
Lung abscess could be the most common preop-
erative impression if there is thick cystic wall and
pneumonic patch surrounding the cyst. Bulla
could be impressed in the presence of a large
amount of air in a thin-walled cyst. The content
of BCs has a great variety of CT density, from thin
watery liquid to hemorrhagic fluid, or to viscous
mucoid material depending on whether there is
hemorrhage, proteinaceous fluid or calcium.3 Soft
tissue attenuation of the cystic content on precon-
trast study is not uncommon.3 Interestingly, type 3
cysts mimicked tumors on postcontrast CT images
in our study. Theoretically, there should be no 
enhancement of the cystic content. It was presumed
that the poor contrast between the cystic content
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and wall of the type 3 cyst was due to inappropriate
timing of acquisition after bolus contrast injection
or poor enhancement of the wall and higher atten-
uation of cystic content. The use of T2-weighted
MRI can reveal homogeneous high signal intensity
of the cystic content of BCs regardless of their CT
attenuation;3 hence, it makes the diagnosis of
type 3 intrapulmonary BCs easier. Unfortunately,
MRI is not routinely used in most circumstances.
Therefore, familiarity with the CT appearance of
intrapulmonary BCs is more important.
Emphysema of adjacent lung parenchyma in
adult intrapulmonary BC (100%) has been demon-
strated on thin-section CT.5 In contrast, there was
a very low incidence of pulmonary emphysema
(10%) in our study, although underestimation
might occur with thicker slice collimation. Further
study with thin-section CT is necessary to clarify
the findings.
Symptomatic intrapulmonary BCs were more
common than those without symptoms.3–5,7 It 
is not uncommon for infants or children to 
develop symptoms, such as fever and pneumonia.
Common clinical presentations included cough,
dyspnea, and no symptoms at all. Chest pain 
and hemoptysis were only reported in adults,
while pneumonia was more common in children.7
Productive cough and chest pain were the two most
common symptoms in our series. Hemoptysis in
patients with intrapulmonary BC was usually mild
and self-limited as in our study. Hemoptysis was
rarely severe and life-threatening in this entity.5,8
From our analysis, CT findings of intrapul-
monary BCs explained their clinical presenta-
tions and were correlated with histopathologic
results. Consolidation and ground glass opacity
(category b) on CT were correlated with pneu-
monia or chronic inflammation on histopathol-
ogy. Patients with CT category b findings had
more clinical symptoms, especially with fever. The
size of intrapulmonary BCs was not correlated
with clinical symptoms. Cysts with air (type 2)
were larger than cysts without air. We presumed
that the presence of air in intrapulmonary BC
might be related to minute communication with
airways or superimposed infection of the cysts.
Interestingly, our results revealed that the presence
of air component (type 2) was not correlated with
clinical symptoms, although all type 2 cysts (9/9)
had at least one clinical symptom while only seven
of 11 cysts without air component were sympto-
matic. The small sample size in our study might
limit the statistical power in data analysis. It was
reported that a higher incidence of intrapulmonary
BC in infants and children was associated with
other malformations.7 However, only one adult
patient with intrapulmonary BC in our series had
associated intralobar pulmonary sequestration.
The differential diagnosis of pulmonary cystic
lesions with content of fluid attenuation should
include other foregut duplication cyst, congenital
cystic adenoid malformation,9,10 infected bullae,
bronchopulmonary sequestration,11 lung abscess
or lung tumor. By using CT or MR angiography,
demonstration of anomalous supplying artery to
the lung parenchymal lesion can establish the di-
agnosis of bronchopulmonary sequestration.12
Surgical removal of BC has been considered to
be the treatment of choice with or without clinical
symptoms because of the potential complications
and risks, including infection, hemorrhage or
malignant change, of non-operated BC.1,2,4,13–15
The risks from surgery are minimal regardless 
of whether it is thoracotomy or video-assisted
thoracoscopic surgery. Preoperative imaging
evaluation is important for guiding appropriate
strategy.
The major limitations of this study are the small
case number and retrospective review without
standard technique of CT study. Using our CT
classification of intrapulmonary BC, we demon-
strated the relationship between imaging and clini-
cal presentations or histopathologic findings,
which has not been described in previous reports.
In summary, there is a wide spectrum of clinical
and imaging presentations in patients with intra-
pulmonary BC. Intrapulmonary BC with the
characteristic findings of thin-walled cyst with
water attenuation is in the minority. They may
look like lung abscesses, infected bullae or even
lung tumors. CT findings of intrapulmonary BC,
especially with surrounding lung parenchymal
change or thick cystic wall, are correlated with
histopathologic findings of pneumonia and clini-
cal symptoms, especially fever. Cysts with an air
component were significantly larger than those
without, but cyst size and air component of in-
trapulmonary BC were not correlated with clinical
symptoms. Knowing the variety and relationship
of CT patterns, histopathologic findings and
clinical presentations of intrapulmonary BC is
important for preoperative differential diagnosis
and understanding this special disease entity.
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